Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Sci Rep ; 10(1): 1552, 2020 01 31.
Article in English | MEDLINE | ID: mdl-32005949

ABSTRACT

The aim is to devise a new short-term intensive insulin therapy (N-SIIT) based on the concept of "treat to target" to avoid hypoglycaemia and was applied it to various diabetic state. We determined dosage of 1 basal and 3 bolus "treat" insulin based on "target" blood glucose level and changed each insulin dose by small units (2 units) every day for 2 weeks. We evaluated the effects of N-SIIT in 74 subjects with type 2 diabetes (male 45, female 29, 64.9 ± 16.6 years old, HbA1c 10.4 ± 2.6%). Glargine U300 ("treat") and morning blood glucose level ("target") was significantly correlated with increasing insulin dose and decreasing blood glucose level in day 1-7, indicating that insulin amount was determined by target blood glucose level and lowered next target blood glucose level. Remission rates were 67.3% (Hypoglycaemia rate 5.6 %) in N-SIIT and 47.3% (Hypoglycaemia rate 38.1%) in conventional SIIT. Required amount of insulin would be automatically determined, depending on each patient pathophysiology and life style. This method is pretty simple, flexible and cheap, and provides information about the dynamic pathophysiological alteration of insulin resistance and glucotoxicity from the profile of blood glucose levels and insulin shot.


Subject(s)
Diabetes Mellitus/drug therapy , Hypoglycemia/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin Glargine/therapeutic use , Aged , Aged, 80 and over , Blood Glucose , Female , Humans , Insulin Resistance , Life Style , Male , Middle Aged , Practice Guidelines as Topic
2.
Biol Pharm Bull ; 38(8): 1175-84, 2015.
Article in English | MEDLINE | ID: mdl-26235580

ABSTRACT

Glomerulonephritis (GN) is a set of pathological conditions that result in the destruction of glomeruli and loss of renal function, commonly leading to the development of end-stage renal disease. Current pharmacotherapy is limited to immunosuppressive therapy. In the present study, we found a novel antinephritic effect of a tricaprylin emulsion in the anti-glomerular basement membrane (anti-GBM) GN rat model. We evaluated the treatment in vivo by comparing administration of the emulsion with administration of a casein kinase II (CK2) inhibitor in this rat model, and performed a gene ontology-based microarray analysis to reveal in silico the detailed mechanism of action. Our results showed that administration of the tricaprylin emulsion, or even tricaprylin alone, significantly ameliorated the anti-GBM antibody-induced renal dysfunction in these rats. We believe that tricaprylin is the key active antinephritic component of the emulsion and might be a promising drug for the effective treatment of nephritis. Moreover, with respect to microarray analysis, we developed a generally applicable and rapid method to compare gene expression profile data for multiple models of nephritis and clinical samples from a public domain microarray database.


Subject(s)
Anti-Glomerular Basement Membrane Disease/drug therapy , Caprylates/therapeutic use , Glomerular Basement Membrane , Kidney/drug effects , Triglycerides/therapeutic use , Animals , Autoantibodies , Caprylates/pharmacology , Computer Simulation , Emulsions , Glomerulonephritis/drug therapy , Kidney/pathology , Kidney Failure, Chronic/prevention & control , Male , Microarray Analysis , Rats, Inbred Strains , Transcriptome , Triglycerides/pharmacology
3.
Gan To Kagaku Ryoho ; 38(13): 2655-7, 2011 Dec.
Article in Japanese | MEDLINE | ID: mdl-22189237

ABSTRACT

The patient is a 62-year-old female who underwent a right hemicolectomy for type-2 ascending colon cancer (moderately-differentiated adenocarcinoma, ss, n0, H0, P0, M0, stage II). Six months after the surgery, a solitary metastatic focus was expressed in the liver S3. Because schizophrenia was present concurrently, tegafur and uracil/folinate (UFT/Leucovorin) treatment was selected and performed for 3 months. Because the tumor shrank afterward, a partial hepatectomy was performed to obtain a curative resection. In a pathological examination of the resected focus, cicatricial/necrotic findings were observed, but no cancer cells were observed; hence, it was determined to be a pathological complete response (CR). In regard to chemotherapy for distant metastasis of colorectal cancer, many molecular-targeted agents are being introduced, thus resulting in more treatment options; however, depending on the patient's background, UFT/LV treatment can be an effective treatment option.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colonic Neoplasms/drug therapy , Leucovorin/therapeutic use , Liver Neoplasms/drug therapy , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Colonic Neoplasms/pathology , Colonic Neoplasms/surgery , Combined Modality Therapy , Female , Humans , Leucovorin/administration & dosage , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Middle Aged , Remission Induction , Tegafur/administration & dosage , Tegafur/therapeutic use , Uracil/administration & dosage , Uracil/therapeutic use
4.
Nihon Kokyuki Gakkai Zasshi ; 48(7): 497-501, 2010 Jul.
Article in Japanese | MEDLINE | ID: mdl-20684212

ABSTRACT

A 72-year-old man complained of dyspnea and epigastric pain. He was admitted to our hospital with progressive dyspnea and abnormal chest radiograph findings. Chest CT scan on admission showed multiple nodular shadows with and without air-bronchograms, vessels or cavitation. Transbronchial and percutaneous lung biopsy specimens demonstrated poorly differentiated carcinoma. Pulmonary metastases were suspected, but their primary origin was unknown. Chest and abdominal CT scans on the 18th hospital day showed a giant tumor of the small intestine and rapid progression of the pulmonary tumor, forming cavitation. The patient's condition worsened, and he died on the 51st hospital day. At autopsy, a final diagnosis of T-cell lymphoma of the small intestine and pulmonary metastases was obtained. This is a rare case which was found primarily based on the characteristic radiologic features of pulmonary metastases.


Subject(s)
Intestinal Neoplasms/diagnosis , Intestine, Small , Lung Neoplasms/secondary , Lymphoma, T-Cell/diagnosis , Aged , Humans , Intestinal Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Lymphoma, T-Cell/pathology , Male , Radiography
5.
Pathol Int ; 60(3): 167-74, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20403042

ABSTRACT

Recently the authors proposed a new staging and grading system for primary biliary cirrhosis (PBC) that takes into account necroinflammatory activity and histological heterogeneity. Herein is proposed a convenient version of this system. Scores for fibrosis, bile duct loss, and chronic cholestasis were combined for staging: stage 1, total score of 0; stage 2, score 1-3; stage 3, score 4-6; and stage 4, score 7-9. Cholangitis activity (CA) and hepatitis activity (HA) were graded as CA0-3, and HA0-3, respectively. Analysis of interobserver agreement was then conducted. Digital images of 62 needle liver biopsy specimens of PBC were recorded as virtual slides on DVDs that were sent to 28 pathologists, including five located overseas. All participants were able to apply this version in all 62 cases. For staging, kappa was 0.385 (fair agreement) and the concordance rate was 63.9%. For necroinflammatory activity, the kappa and concordance rate were 0.110 (slight agreement) and 36.9% for CA, and 0.197 (slight agreement) and 47% for HA, respectively. In conclusion, this new staging and grading system for PBC seems to be more convenient and practical than those used at present, but more instruction and guidance are recommended for the grading of necroinflammatory activity in practice.


Subject(s)
Bile Ducts/pathology , Cholestasis/pathology , Liver Cirrhosis, Biliary/classification , Liver Cirrhosis, Biliary/pathology , Liver/pathology , Aged , Cholestasis/classification , Disease Progression , Female , Fibrosis/pathology , Hepatitis C/classification , Hepatitis C/pathology , Humans , Inflammation/classification , Inflammation/pathology , Male , Middle Aged , Observer Variation
6.
Cancer ; 116(2): 393-9, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-19908259

ABSTRACT

BACKGROUND: The authors successfully adopted an interesting and effective treatment for hepatocellular carcinoma (HCC) referred to as angiographic subsegmentectomy (AS). This treatment involved simultaneous embolization of the peripheral feeding artery and the portal vein. The result was that almost all of the HCC and peripheral liver parenchyma developed complete anatomic necrosis. METHODS: To determine the effectiveness of this method, the authors retrospectively studied the local recurrence rates of 49 solitary HCCs and the long-term survival rates of 120 patients with HCC between 2000 and 2008. RESULTS: The results indicated that, in 31 small, solitary HCCs (<2.0 cm), the local recurrence rate was only 9.6%; and, in 10 slightly larger HCCs (<3.0 cm), the local recurrence rate was only 10%. The 5-year, 8-year, and 10-year survival rates for patients with stage I and stage I/Child-Pugh grade A HCC were 74.27% and 77.65%, 53.05% and 51.76%, and 53% and 51.76%, respectively; and the 5-year, 8-year, and 10-year survival rates for patients with stage II and stage II/Child-Pugh grade A HCC were 66.21% and 71.41%, 39.9% and 39.60%, and 29.92% and 25%), respectively. There were no severe complications. CONCLUSIONS: AS should be investigated further as potential first-line therapy for the treatment of patients with stage I and II HCC.


Subject(s)
Angiography , Carcinoma, Hepatocellular/surgery , Chemoembolization, Therapeutic/methods , Liver Neoplasms/surgery , Tomography, X-Ray Computed/methods , Adult , Aged , Aged, 80 and over , Female , Hepatic Artery , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Portal Vein , Survival Rate , Treatment Outcome
8.
Int J Urol ; 11(9): 801-4, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15379951

ABSTRACT

We report the case of a 59-year-old man with a metachronous development of phyllodes tumor and adenocarcinoma of the prostate. He complained of urinary obstruction and transurethral resections of the prostate (TUR-P) had been performed six times in 10 years. Microscopic examination showed cystically dilated glands consisting of bizarre cells with pleomorphic, hyperchromatic nuclei in the stroma at the sixth TUR-P. Radical prostatectomy was performed against recurrences and adenocarcinoma was incidentally detected. Apparent up-regulation of proliferative nuclear antigens (PCNA), but not p53, was observed in the prostatectomy specimen by Western blotting. Active proliferation of stromal cells is considered to have caused the recurrent obstructive symptom.


Subject(s)
Adenocarcinoma/pathology , Neoplasms, Multiple Primary/pathology , Phyllodes Tumor/pathology , Prostatic Neoplasms/pathology , Stromal Cells/pathology , Urologic Diseases/etiology , Adenocarcinoma/complications , Adenocarcinoma/surgery , Constriction, Pathologic , Humans , Male , Middle Aged , Neoplasms, Multiple Primary/complications , Neoplasms, Multiple Primary/surgery , Phyllodes Tumor/complications , Phyllodes Tumor/surgery , Prostatic Neoplasms/complications , Prostatic Neoplasms/surgery , Recurrence
9.
J Gastroenterol Hepatol ; 18(9): 1076-80, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12911666

ABSTRACT

AIMS: The early stage of hepatocarcinogenesis is not well understood pathologically and clinically. The present study was designed to define small (early) hepatocellular carcinoma (HCC) angiographically using the angio-helical computed tomography (CT) system. METHODS: Arterial portography CT and hepatic arteriography CT were carried out in 29 patients in whom small HCC < or = 20 mm was detected during follow-up. RESULTS: There were 17 males and 12 females, aged 47 to 85 years. The offending virus was hepatitis B in four, hepatitis C in 24 and no virus marker in one case. The follow-up period varied from less than a year to 17 years, averaging 6.4 years. The underlying disease was cirrhosis in 12 and chronic hepatitis in 17 cases. The mass was solitary in 16 and multiple in 13 cases, while the size of the mass ranged from 8-20 mm. All lesions were low in attenuation on arterial portography CT, and in 23 of 30 lesions hepatic arteriography CT showed high attenuation, suggesting arterial blood supply. In the remaining 7 cases, lesions were perhaps in the transition from portal to arterial. CONCLUSIONS: It was concluded that HCC develops frequently in a liver with chronic hepatitis, often muticentrically, and that early HCC lesions are more often overt HCC already with arterial blood supply, rather than extremely well-differentiated supplied by the portal vein as generally believed.


Subject(s)
Angiography/methods , Carcinoma, Hepatocellular/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/pathology , Female , Follow-Up Studies , Humans , Liver Neoplasms/pathology , Male , Middle Aged
10.
Cancer ; 97(4): 1051-6, 2003 Feb 15.
Article in English | MEDLINE | ID: mdl-12569605

ABSTRACT

BACKGROUND: The therapeutic results of nonsurgical treatment for patients with hepatocellular carcinoma (HCC) have been poor, and improved treatments are needed. The authors recently developed a new technique called angiographic subsegmentectomy for the treatment of patients with small HCC. METHODS: The technique includes confirming the diagnosis of small HCC using a helical computed tomography (CT) scan combined with an angiography system for identifying the tumor-feeding subsegmental hepatic artery, injecting lipiodol containing farmorubicin until it enters the portal vein in sufficient amounts, and injecting sponge particles into the hepatic artery for embolization. Occlusion of the hepatic artery with gel particles and occlusion of the portal vein by lipiodol induce infarction necrosis, which encompasses the entire tumor and the surrounding liver parenchyma. RESULTS: The treatment was given to 23 patients with 30 HCC tumors that measured < 20 mm in greatest dimension. It was successful in all 23 patients. Serum alanine aminotransferase levels were elevated to a significant level in the majority of patients after treatment, mild ascites developed in three patients, and the patients complained of pain and fever posttreatment that were controlled readily. No patients developed hepatic failure. Only one patient developed recurrent disease posttreatment at 1.5 years, for a recurrence rate of 5% at 1 year and 6.6% at 1.5 years, a rate that has never been achieved with other treatment modalities. CONCLUSIONS: Angiographic subsegmentectomy is a novel treatment for patients with small HCC. The results indicated that it is equivalent to undergoing small resection and is superior to conventional arterial chemoembolization.


Subject(s)
Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic , Liver Neoplasms/therapy , Aged , Angiography , Carcinoma, Hepatocellular/blood supply , Carcinoma, Hepatocellular/pathology , Female , Hepatic Artery , Humans , Liver Neoplasms/blood supply , Liver Neoplasms/pathology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...